Key Takeaways:
Option Care Health Inc. (OPCH) reported second-quarter revenue of $1.44 billion, topping the $1.42 billion FactSet consensus, as the home infusion provider posted sequential improvements across revenue, adjusted EBITDA and adjusted earnings per share.
"We delivered a solid quarter that exceeded our internal expectations, driven by continued execution across our core infusion business," said John Rademacher, chief executive officer of Option Care Health, in a statement. "The sequential improvement in our financial metrics reflects the strength of our operating model and the growing demand for home-based care."
Revenue for the three months ended June 30 rose 1.9 percent from $1.42 billion a year earlier. Net income climbed to $53.91 million, or $0.35 per diluted share, from $50.52 million, or $0.31 per share, in the same period last year. For the first half of 2026, revenue totaled $2.79 billion, up from $2.75 billion in the prior-year period, while net income reached $99.26 million, or $0.64 per share, compared with $97.27 million, or $0.59 per share.
The company maintained its full-year revenue outlook of $5.68 billion to $5.78 billion, bracketing the $5.71 billion FactSet estimate, while narrowing its adjusted earnings per share forecast to $1.85 to $1.92, above the $1.83 consensus. Shares surged 7.6 percent to $24.20 in afternoon trading, though the stock remains down about 25 percent year to date. Of the 13 analysts covering OPCH, the average rating is Accumulate with a price target of $28.08, implying roughly 25 percent upside from current levels.
The narrowed guidance range signals management's confidence in sustaining operational momentum through the second half, even as the broader healthcare services sector faces headwinds from labor costs and reimbursement pressures. Option Care Health, which operates more than 87 pharmacies and 109 ambulatory infusion suites, is positioned to benefit from the secular shift toward lower-cost home infusion settings as hospitals and insurers seek to reduce inpatient spending. The company's next quarterly report is expected in late October.
This article is for informational purposes only and does not constitute investment advice.
